Chagas Disease and Transfusion Risk in Italy: The Results of a National Survey.

Chagas disease Tripanosoma cruzi blood transfusion safety epidemiological surveillance transfusion transmissible infection

Journal

Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317

Informations de publication

Date de publication:
25 Oct 2022
Historique:
received: 13 09 2022
revised: 19 10 2022
accepted: 22 10 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 12 11 2022
Statut: epublish

Résumé

Universal serological screening in endemic areas is essential for preventing Chagas disease transmission by transfusions, while in non-endemic areas, screening is provided only to donors exposed to the infection risk. In this respect, in order to ensure high and uniform standards of quality and safety of blood components, the Italian National Blood Centre conducted a survey to detect information on management of donors at risk of Chagas disease and on the current transfusion risk. The National Blood Centre conducted a survey on preventive measures for Chagas disease in the years 2020-2021. Survey results are broadly representative of the national situation; out of 24,269 tested donors, only 15 donors were confirmed positive (0.4 out of 100,000 donors). This rate is lower than the number of positive donors (72/100,000) for transfusion transmissible infections (HIV, HBV, HCV, and In Italy,

Sections du résumé

BACKGROUND BACKGROUND
Universal serological screening in endemic areas is essential for preventing Chagas disease transmission by transfusions, while in non-endemic areas, screening is provided only to donors exposed to the infection risk. In this respect, in order to ensure high and uniform standards of quality and safety of blood components, the Italian National Blood Centre conducted a survey to detect information on management of donors at risk of Chagas disease and on the current transfusion risk.
METHODS METHODS
The National Blood Centre conducted a survey on preventive measures for Chagas disease in the years 2020-2021.
RESULTS RESULTS
Survey results are broadly representative of the national situation; out of 24,269 tested donors, only 15 donors were confirmed positive (0.4 out of 100,000 donors). This rate is lower than the number of positive donors (72/100,000) for transfusion transmissible infections (HIV, HBV, HCV, and
CONCLUSIONS CONCLUSIONS
In Italy,

Identifiants

pubmed: 36364982
pii: pathogens11111229
doi: 10.3390/pathogens11111229
pmc: PMC9697205
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Clin Res Cardiol. 2014 Jan;103(1):1-10
pubmed: 23989652
Clin Infect Dis. 2008 Mar 1;46(5):e44-7
pubmed: 18257698
Blood Transfus. 2015 Oct;13(4):540-50
pubmed: 26513769
Travel Med Infect Dis. 2022 May-Jun;47:102284
pubmed: 35245657
Hematol Transfus Cell Ther. 2019 Jul - Sep;41(3):262-267
pubmed: 31085149
Front Public Health. 2019 Jul 02;7:166
pubmed: 31312626
Clin Microbiol Infect. 2016 Sep;22(9):788-792
pubmed: 27317907
Clin Microbiol Infect. 2014 Jul;20(7):706-12
pubmed: 24329884
Vaccine. 2016 Jun 3;34(26):2996-3000
pubmed: 27026146

Auteurs

Ilaria Pati (I)

National Blood Centre, Italian National Institute of Health, 00161 Rome, Italy.

Mario Cruciani (M)

National Blood Centre, Italian National Institute of Health, 00161 Rome, Italy.

Francesca Masiello (F)

National Blood Centre, Italian National Institute of Health, 00161 Rome, Italy.

Francesco Barone (F)

National Blood Centre, Italian National Institute of Health, 00161 Rome, Italy.

Giacomo Silvioli (G)

National Blood Centre, Italian National Institute of Health, 00161 Rome, Italy.

Massimo La Raja (M)

National Blood Centre, Italian National Institute of Health, 00161 Rome, Italy.

Simonetta Pupella (S)

National Blood Centre, Italian National Institute of Health, 00161 Rome, Italy.

Vincenzo De Angelis (V)

National Blood Centre, Italian National Institute of Health, 00161 Rome, Italy.

Classifications MeSH